Therapeutic response and prognostic factors of 14 dogs undergoing transcatheter arterial embolization for hepatocellular masses: A retrospective study
Journal of Veterinary Internal Medicine · 01.07.2023 · 37 (4) · 1455-1465
DOI: 10.1111/jvim.16746 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, online erschienen am 01.07.2023. Verfasst von Yuta Kawamura und 5 weiteren Autor:innen. Beteiligte Einrichtung: Kawamura Animal Hospital, Niigata City, Japan. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Embolization, Therapeutic, Dog Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Information regarding the therapeutic effect and outcome of transcatheter arterial embolization (TAE) for hepatic masses is limited in veterinary medicine. Hypothesis/Objectives To analyze the therapeutic response, outcome (overall survival), and their predictors in dogs that underwent TAE for primary hepatocellular masses. We hypothesized that larger pre-TAE tumors would be associated with worse outcomes. Animals Fourteen client-owned dogs.
Methods
Retrospective study. Medical records between 1 September 2016 and 30 April 2022 were reviewed to identify dogs treated with TAE for hepatic masses diagnosed as hepatocellular origin by cytological or histopathological examination. Computed tomography images were compared before and after TAE. The univariate Cox proportional hazards test was performed to assess the associations between variables and survival. Univariate linear regression analysis was performed to assess the associations between variables and the tumor reduction percentage: ([post-TAE volume − pre-TAE volume]/pre-TAE volume) × 100.
Results
The median survival time was 419 days (95% confidence interval, 82-474). History of intra-abdominal hemorrhage (P = .03) and pre-TAE tumor volume/body weight (P = .009) were significantly associated with overall survival. The mean reduction percentage was −51% ± 40%. Pre-TAE tumor volume/body weight ratio (cm3/kg; P = .02, correlation coefficient = 0.704) was significantly correlated with the volume reduction percentage.
Conclusions
History of intra-abdominal hemorrhage and large pre-TAE tumor volume/body weight ratio could be predictive factors for adverse outcomes after TAE. Pre-TAE tumor volume/body weight ratio could be a predictive factor for therapeutic effect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Kawamura Animal Hospital, Niigata City, Japan.
- Department of Radiology, Division of Diagnostic Radiology, Faculty of Medicine, Yamagata University, Iida-Nishi, Japan.
ORCID-Profile: Yuta Kawamura
Zitieren
APA
Kawamura, Y., Itou, H., Kida, A., Sunakawa, H., Suzuki, M., & Kawamura, K. (2023). Therapeutic response and prognostic factors of 14 dogs undergoing transcatheter arterial embolization for hepatocellular masses: A retrospective study. Journal of Veterinary Internal Medicine, 37(4), 1455-1465. https://doi.org/10.1111/jvim.16746
Vancouver
Kawamura Y, Itou H, Kida A, Sunakawa H, Suzuki M, Kawamura K. Therapeutic response and prognostic factors of 14 dogs undergoing transcatheter arterial embolization for hepatocellular masses: A retrospective study. Journal of Veterinary Internal Medicine. 2023;37(4):1455-1465. doi:10.1111/jvim.16746
BibTeX
@article{Kawamura2023,
author = {Kawamura, Yuta and Itou, Hiroki and Kida, Akitomo and Sunakawa, Hiroki and Suzuki, Moe and Kawamura, Kenji},
title = {Therapeutic response and prognostic factors of 14 dogs undergoing transcatheter arterial embolization for hepatocellular masses: A retrospective study},
journal = {Journal of Veterinary Internal Medicine},
year = {2023},
volume = {37},
number = {4},
pages = {1455--1465},
doi = {10.1111/jvim.16746}
}
EUVIMED